Taking oligonucleotide research to its full therapeutic potential

You are here:

Home
Society News

Society News

……………

Past Society News

……………

Coronavirus Highlights Urgent Need for Science-Backed Research

LUMC and Radboudumc Launch Center for RNA Therapy for Ultrarare Diseases

Alnylam Receives Approval for GIVLAARI™ (givosiran) by the U.S. Food and Drug Administration (FDA)

Join the Conversation

……………

A Twitter List by OTSociety

Featured Members

……………

Interview with Amalia Sapag

Interview with Mirjana Kujacic

Interview with Marcin Kortylewski